Cholesterol and Apoe: A Target for Alzheimers Disease Therapeutics

Author(s): Daniela Fenili, JoAnne McLaurin

Journal Name: Current Drug Targets - CNS & Neurological Disorders
Continued as CNS & Neurological Disorders - Drug Targets

Volume 4 , Issue 5 , 2005


Alzheimers disease (AD) is a debilitating disease that affects many people. In order to reduce the number of people diagnosed with this disease, drug strategies need to be implemented that target early steps in disease pathogenesis. Elevated cholesterol levels and presence of the apolipoprotein E 4 allele increase AD risk. How these two factors may contribute to AD pathogenesis and some therapeutic strategies for alleviating AD risk will be discussed.

Keywords: alzheimers disease, cholesterol, apoe, statins, membrane fluidity, fibrillogenesis

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [553 - 567]
Pages: 15
DOI: 10.2174/156800705774322085
Price: $58

Article Metrics

PDF: 3